Keisuke Endo

Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease

Daisuke Miyamori, Marenao Tanaka, Tatsuya Sato et al. · Journal of the American Heart Association · 2023 · 29 citations · Full text

Medicine, Cardiology, Internal Medicine +16

Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan

Keisuke Endo, Takayuki Miki, Takahito Itoh et al. · Internal Medicine · 2021 · 26 citations · Full text

Medicine, Internal Medicine, Diabetology +10

Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period

Kazuma Mori, Marenao Tanaka, Tatsuya Sato et al. · Hepatology Research · 2024 · 25 citations · Full text

Medicine, Nephrology, Clinical Nutrition +14

Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis

Kazuma Mori, Yukinori Akiyama, Marenao Tanaka et al. · Journal of Gastroenterology and Hepatology · 2024 · 21 citations · Full text

Medicine, Internal Medicine, Pathology +10

Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses

Kazuma Mori, Marenao Tanaka, Itaru Hosaka et al. · Hypertension Research · 2023 · 19 citations

Veterinary Medicine, Cardiology, Metabolic Physiology +12